cTAPcTAPcTAPcTAP
  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

2019 WMS Abstract – 48-Week Changes in NSAA

Home / Blog / Abstracts / 2019 WMS Abstract – 48-Week Changes in NSAA

2019 WMS Abstract – Lean Body Mass and Motor Function in DMD Patients
2019 WMS Abstract – Prognostic score for loss of walking ability in DMD

2019 WMS Abstract – 48-Week Changes in NSAA

Consistency of 48-week changes in North Star Ambulatory Assessment (NSAA) between Duchenne muscular dystrophy (DMD) natural history data and clinical trial placebo arms, after adjustment for prognostic factors

View the Full PDF

02
Apr 2019
By SCsbox3AdminAbstractsComments Off on 2019 WMS Abstract – 48-Week Changes in NSAA

Read the latest

  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation
  • A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy
  • Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study
  • Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trials
  • New study may help more DMD patients be included in clinical trials

COLLABORATIVE TRAJECTORY
ANALYSIS PROJECT

501 (c) 3 nonprofit organization

Cambridge Innovative Center
One Broadway, Cambridge, MA 02142

T: 617-555-5555
E: info@ctap-nmd.org

Terms & Conditions
Privacy Policy

© 2026 Collaborative Trajectory Analysis Project. All rights reserved.

  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

Terms and Conditions - Privacy Policy